Some indications of Cisapride to be deleted.

Published: 2000-09-19 13:20:00

Updated: 2000-09-19 13:20:00

The KFDA announced to cancel some indications of Cisapride such as early satiety feeling, hear burn and abdominal distention, anorexia, nausea, vomiting, upper abdominal pain, belching in sour, functional gastric dyspepsia (chronic gastritis), vagus or gastrotomic syndrome and chronic constipatio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK